Good MorningEquity markets extended the rebound in stocks to near the recent high on Tuesday but traders and investors alike are cautioned not to read too much into the move. Not only was the move driven by an absence of news but it occurred during a holiday-shortened trading week. The takeaway is that Tuesday's action appears bullish but may not lead to much without a true catalyst to induce the market to buy stocks.
Wednesday's action will be more of the same. The question is if the market will end the day up or down and the difference will be telling. A down market suggests traders are fearful of what might happen over the extended holiday weekend while an up market is the opposite. Next week the market will get back in gear as investors start to prep for the final days of the year and what could be a lackluster holiday shopping season. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Markets | |
The CBD industry has faced its share of hurdles but one thing is clear: It is here to stay and should grow at a high double-digit compound annual growth rate (CAGR) for the next six years or more. As of 2021, the CBD industry was valued at just over $12.8 billion and is expected to grow at a 20% C... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Markets | | The classic 60/40 portfolio, consisting of 60% stocks and 40% bonds, has served investors well over the years. A very basic 60/40 allocation, which includes international securities, might consist of the SPDR Portfolio MSCI Global Stock Market ETF (NYSEARCA: SPGM) combined with the Vanguard Total In... Read the Full Story |
|
Technology | |
The S&P 500 index is up 15% from the lows of last month. This means that investors have a lot to be happy about going into Thanksgiving week, especially given how bleak things have looked at various times in recent months. Some signs of inflation slowing have started to appear (we’re not... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Technology | | In the first week of November, Salesforce Inc. (NYSE: CRM) announced it would let go of employees after demand lightened for its enterprise software. This is certainly not good news and it touches on the larger concerns that have affected earnings for front-office software this quarter. Salesforce a... Read the Full Story |
|
Technology | |
The outlook for the semiconductor industry has been on shaky footing for the last several quarters but you wouldn’t be able to tell by looking at institutional activity through Analog Devices Inc. (NASDAQ: ADI). The institutions have rotated their holdings and they’ve been net bearish ... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Technology | | CenturyLink merged with Qwest to become the third-largest telecommunications company in the U.S. in 2010. The Company continued to gobble up technology companies like Savvis, a cloud infrastructure company in 2012 and broadband provider Level 3 Communications in 2017. The Company changed its name fr... Read the Full Story |
|
Technology | |
Despite a fiscal first-quarter earnings report that beat consensus estimates, analysts are giving Cisco Systems (Nasdaq: CSCO) a HOLD rating for now. The report revealed that earnings for the computer networking firm rose 5% year-over-year through the quarter ending on October 29, up 86 cents. In ... Read the Full Story |
|
Retail/Wholesale | |
The sell-side activity has been robust for Dick’s Sporting Goods (NYSE: DKS) over the past 12 months and it is capping gains for the stock. Insiders, institutions and short-sellers are using the $115 level as a ceiling that has the stock trapped in a range that has persisted since the late s... Read the Full Story |
|
Markets | |
If you want to invest in covered calls the Global X Funds NASDAQ 100 ETF (NASDAQ: QYLD) is something you should check out. Better yet, if you want to get a high double-digit yield in a stock with a long track record of successive monthly dividend payments this should be on your list. It is an ETF ... Read the Full Story |
|
Technology | |
Books. Makeup. Socks. Bottles of hot sauce. When it comes to stocking stuffers, Santa has many budget-friendly options. Investors in search of inexpensive stocks, on the other hand, have limited choices — at least when it comes to those stocks that have good fundamentals.
This year’s ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California. | | View Today's Stock Pick |
|
